Genomic and transcriptomic features associated with responses and outcomes of third-generation tyrosine kinase-inhibitor therapy in chronic myeloid leukemia
Xiaoshuai Zhang, Lu Yu, Zongru Li, Yazhen Qin, Yueyun Lai, Robert Peter Gale, Xiaojun Huang, Qian Jiang Leukemia
· Springer Nature
· 2026-11-12
· DOI: 10.1038/s41375-026-03182-z
Аннотация
Leukemia, Published online: 12 November 2026; doi:10.1038/s41375-026-03182-z Genomic and transcriptomic features associated with responses and outcomes of third-generation tyrosine kinase-inhibitor therapy in chronic myeloid leukemia
Xiaoshuai Zhang, Lu Yu, Zongru Li, Yazhen Qin, Yueyun Lai, Robert Peter Gale et al. Genomic and transcriptomic features associated with responses and outcomes of third-generation tyrosine kinase-inhibitor therapy in chronic myeloid leukemia. // Leukemia. – 2026. – DOI: 10.1038/s41375-026-03182-z. – URL: https://www.nature.com/articles/s41375-026-03182-z
Xiaoshuai Zhang, Lu Yu, Zongru Li, Yazhen Qin, Yueyun Lai, Robert Peter Gale, Xiaojun Huang, & Qian Jiang (2026). Genomic and transcriptomic features associated with responses and outcomes of third-generation tyrosine kinase-inhibitor therapy in chronic myeloid leukemia. Leukemia. https://doi.org/10.1038/s41375-026-03182-z
Xiaoshuai Zhang, et al. “Genomic and transcriptomic features associated with responses and outcomes of third-generation tyrosine kinase-inhibitor therapy in chronic myeloid leukemia.” Leukemia, 2026. doi:10.1038/s41375-026-03182-z.
@article{Zhang2026,
title = {Genomic and transcriptomic features associated with responses and outcomes of third-generation tyrosine kinase-inhibitor therapy in chronic myeloid leukemia},
author = {Zhang, Xiaoshuai and Yu, Lu and Li, Zongru and Qin, Yazhen and Lai, Yueyun and Gale, Robert Peter and Huang, Xiaojun and Jiang, Qian},
journal = {Leukemia},
year = {2026},
doi = {10.1038/s41375-026-03182-z},
url = {https://www.nature.com/articles/s41375-026-03182-z}
}